• Skip to main content
  • Skip to secondary menu
  • Skip to footer

OPINT

OPINT stands for Operational Intelligence

  • About
    • GDPR
  • Sponsored Post
    • Make a Contribution
  • Job Board
  • Contact

CMR Surgical raises $600 million in Series D financing

June 28, 2021 By admin Leave a Comment

Funding fully supports the accelerated continued global expansion and commercial scale up of the business

Financing round led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group

The largest ever MedTech private financing round worldwide to help bring Versius® to hospitals around the worldi

CAMBRIDGE, UK – CMR Surgical (CMR or “the Company”), a global surgical robotics business, today announces that it has raised $600 million (£425 million) in a Series D financing. The round was led by SoftBank Vision Fund 2ii and co-led by Ally Bridge Group and will support the Company’s mission to make keyhole surgery accessible to more people worldwide. The funds will be used to increase the global commercialisation of Versius®, CMR’s next-generation surgical robotic system, and further develop its digital ecosystem.

CMR works with surgeons and hospitals to provide an optimal tool to make robotic keyhole surgery universally accessible and affordable. Versius’ size, portability and versatility have made it very popular with hospitals and surgeons around the world. As part of CMR’s ongoing international expansion, Versius has been successfully launched in multiple geographies worldwide including across Europe, Australia, India and the Middle East. Global demand for CMR’s surgical robot continues to grow with significant further momentum anticipated.

The Series D secures the financing to fully execute CMR’s strategy to rapidly accelerate its geographical expansion and builds upon the framework the Company has established to grow a long-term independent global business. The new funds also support the continued development of the system’s digital framework, including new technological developments such as Versius Connect, an app for surgeons using the Versius surgical robotic system.

In addition to SoftBank Vision Fund 2 and Ally Bridge Group, the financing was supported by other new international investors including RPMI Railpen, Tencent and Chimera, broadening the geographic scope of the shareholder base. Existing investors, including LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare, also participated in the round.

Per Vegard Nerseth, Chief Executive Officer of CMR, commented: “This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem. I would also like to thank our existing investors for their long-term support.”

Yanni Pipilis, Managing Partner for SoftBank Investment Advisers, commented: “Demand for minimally invasive robotic surgery is growing rapidly among surgeons and patients yet high costs have historically hindered adoption. CMR Surgical is transforming surgical robotics to convert underpenetrated open & laparoscopic procedures in new international markets where robotic surgeries are less prevalent such as India, the Middle East and Latin America. We look forward to working with CMR in its mission to make robotic keyhole surgery available to everyone.”

Charles Chon, Partner and Head of MedTech, Ally Bridge Group, said: “As life science-dedicated specialists and active investors in surgical robotics, we believe the user-friendliness and cost-effectiveness of the Versius system allows a meaningfully differentiated robotic experience that democratizes robotic surgery both procedurally and geographically. We are proud to support CMR as a hallmark of UK innovation and a solution for all surgeons and their patients.”

J.P. Morgan acted as sole placement agent on CMR Surgical’s Series D financing.

The Versius Surgical Robotic System
Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

About CMR Surgical Limited
CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot. Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.

i PitchBook, May-21
ii As of the date of this press release, SoftBank Group Corp. has made capital contributions to allow investments by SoftBank Vision Fund 2 (“SVF 2”) in certain portfolio companies. The information included herein is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy limited partnership interests in any fund, including SVF 2. SVF 2 has yet to have an external close, and any potential third-party investors shall receive additional information related to any SVF 2 investments prior to closing.

Source: CMR Surgical

Filed Under: News Tagged With: medtech, venture capital

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • “Buy” Recommendation: Cloudflare Positioned for Sustained Growth and Profitability
  • Navigating the Expanding World of Cybersecurity with CybersecurityMarket.com
  • A New Front Opens: North Korea Joins Russia’s War Effort
  • South Korea’s Innovation Showcase: 24 Startups Take Center Stage at TechCrunch Disrupt 2024
  • Spain’s Digital Nomad Visa: A Gateway to a Work-Life Adventure in the Sun
  • Smartoptics enters long-term partnership with US technology solutions provider WIN Technology
  • The Ever-Present Challenge: Why Cybersecurity Remains a Critical Concern
  • European Shoppers Cut Spending Despite Easing Inflation, BCG Survey Finds
  • APA Poll Reveals Future of Nation, Economy, and 2024 Election as Leading Stressors for Americans
  • Gartner Identifies the Top 10 Strategic Technology Trends for 2025

Media Partners

  • Cybersecurity Market
  • Media Partners
Veza Secures $108 Million in Series D Funding to Redefine Identity Security
Thales Enhances Imperva’s API Security with Advanced BOLA Detection and Response Capabilities
Five Elms Capital Closes $1.1B Fund VI to Back the Next Generation of Scalable Software Leaders
Halcyon’s TRIP: A Global Bounty Against Ransomware
Secure Ideas Achieves CREST Accreditation and CMMC Level 1 Compliance
Terra Security Wins AWS, CrowdStrike, and NVIDIA Cybersecurity Startup Accelerator 2025
NTT DATA and Rubrik Unite to Fortify Global Cyber Resilience Against Ransomware
SecAI Debuts at RSA 2025, Redefining Threat Investigation with AI
Aviva and CyberCube Leverage AI to Strengthen Cyber Risk Analytics
Black Hat Asia 2025, April 3-4, Marina Bay Sands Expo & Convention Centre in Singapore
Studio Tel Aviv
Virtual Travel Guide
Transportational
Photo Studio
ESN
Technology Conference
Defense Market
Digital Market
Domain Aftermarket
Calendarial

Media Partners

  • Defense Market
  • Media Partners
L3Harris Secures $999 Million U.S. Navy Contract for Resilient Communications Technology
Counter UAS Technology Europe 2024: Echodyne to Address Key C-UAS Conference Amidst Rapid Expansion into European Market
Motorola Solutions Acquires RapidDeploy to Transform Emergency Response Technology
Elbit Systems Awarded a $180 Million Contract From the Israeli MOD to Provide a new Mission Training Center for its F-16 Fleet
CACI to acquire Azure Summit Technology for $1.275 billion
Elbit Systems Ltd. has been awarded contracts $760 million for the supply of ammunition to the Israeli Ministry of Defense
AI Defense Forum will take place on September 13 2023 in Tysons, Virginia
Farnborough International Airshow 2024: Registration Now Open
Leonardo DRS Reports Strong Q3 2024 Results; Revenue and Profitability Surge
V2X Secures $103 Million Contract for U.S. Navy C-26 Aircraft Maintenance
Israel News
Press Club
Press Media Release
Nameable
Analysis
Defense Market
Digital Market
Briefly
Cyber Security Market
Policymaker

Copyright © 2022 OPINT.com